Anti-ICAM in inflammatory disease.
Rothlein
R
R
Boehringer Ingelheim, Ridgefield, CT 06877, USA.
D000911:Antibodies, Monoclonal / Q000008:administration & dosage / Q000627:therapeutic use*; D001172:Arthritis, Rheumatoid / Q000628:therapy; D002986:Clinical Trials as Topic; D006084:Graft Rejection / Q000628:therapy; D006801:Humans; D007074:Immunoglobulin G / Q000008:administration & dosage / Q000627:therapeutic use*; D018799:Intercellular Adhesion Molecule-1 / Q000276:immunology*
D000911:Antibodies, Monoclonal; D007074:Immunoglobulin G; D018799:Intercellular Adhesion Molecule-1